Students in leadership positions learn about brain tumors and gain real world experience in running a non-profit business while raising funds for brain tumor research. Beneficiaries of the money we raise are Barrow Neurological Institute, National Brain Tumor Society, Phoenix Children's Hospital, Translational Genomics Research Institute, and University of Arizona.

"Be the change you wish to see in the world..." Gandhi

Our Beneficiaries

  • University of AZ Research Centers
    University of AZ Research Centers
  • “Charity is a supreme virtue, and the great channel through which the mercy of God is passed on to mankind. It is the virtue that unites men and inspires their noblest efforts.”

    — Conrad Hilton

Brain Tumor News

A Portuguese research team discovered a mechanism that controls the spread of glioblastoma, a form of malignant brain tumor, the Gulbenkian Institute of Science (IGC) said in a statement on Friday.

Glioblastoma is the deadliest form of brain cancer. Most patients survive about a year. But experimental treatments are helping some patients live longer, including one young father who's had promising results thanks to cutting edge treatments.

In an ongoing phase III clinical trial, a brain cancer vaccine has significantly prolonged the life of participants with glioblastoma.

A new multi-institutional project is studying cancer biology and care to identify why minority children have worse cancer outcomes compared to their white peers.

A research team , in collaboration with Prof. LIU Bin from the University of Singapore, reported the first NIR-II fluorescent molecule with aggregation-induced-emission (AIE) characteristics for dual fluorescence and photoacoustic imaging.

Glioblastoma multiforme is the commonest type of brain cancer, with "in-built" defense mechanisms that lend it resilience. Will new discoveries about the defenses help to eliminate this cancer more efficiently?

View Previous News Articles - Click Here!